Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 19,742 | 17,524 | 15,025 | 8,653 | 3,883 |
| Operating Income | -19,742 | -17,524 | -15,025 | -8,653 | -3,883 |
| Interest Expense | 0 | 0 | 0 | 0 | 43 |
| Other Income | 2,387 | 4,090 | 3,149 | -1,152 | 0 |
| Pre-tax Income | -17,355 | -13,434 | -11,876 | -9,805 | -3,926 |
| Income Tax | N/A | -229 | N/A | N/A | N/A |
| Net Income Continuous | -17,355 | -13,205 | -11,876 | -9,805 | -3,926 |
| Net Income | $-17,355 | $-13,205 | $-11,876 | $-9,805 | $-3,926 |
| EPS Basic Total Ops | -659.67 | -730.88 | -1,034.28 | -1,191.67 | -899.37 |
| EPS Basic Continuous Ops | -660.68 | -729.26 | -1,030.81 | -1,187.23 | -898.23 |
| EPS Diluted Total Ops | -659.67 | -730.88 | -1,034.28 | -1,191.67 | -899.37 |
| EPS Diluted Continuous Ops | -660.68 | -729.26 | -1,030.81 | -1,187.23 | -898.23 |
| EPS Diluted Before Non-Recurring Items | -659.67 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-19,542 | $-17,325 | $-14,957 | $-8,635 | $-3,877 |